表紙
市場調查報告書

全球幹細胞治療市場:病原,治療,用途,終端用戶,各地區 - 規模,佔有率,趨勢,及預測

Stem Cell Therapy Market, by Source by Therapy Type,by Application, by End User, by Region - Size, Share, Trends, and Forecast 2018 - 2026

出版商 Coherent Market Insights 商品編碼 906227
出版日期 內容資訊 英文 157 Pages
商品交期: 2-3個工作天內
價格
Back to Top
全球幹細胞治療市場:病原,治療,用途,終端用戶,各地區 - 規模,佔有率,趨勢,及預測 Stem Cell Therapy Market, by Source by Therapy Type,by Application, by End User, by Region - Size, Share, Trends, and Forecast 2018 - 2026
出版日期: 2019年07月18日內容資訊: 英文 157 Pages
簡介

本報告提供全球幹細胞治療市場的相關調查,提供市場趨勢和影響,成長及阻礙因素,病原·治療·用途·終端用戶·各地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 調查的目的及假設

  • 調查目的
  • 假設
  • 簡稱

第2章 市場概要

  • 報告的說明
    • 市場定義及範圍
  • 摘要整理
    • 各病原
    • 不同治療
    • 各用途
    • 各終端用戶
    • 各地區
  • COM (Coherent Opportunity Map)

第3章 市場動態,法規,趨勢分析

  • 市場動態
    • 成長要素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 市場趨勢
  • 主要的開發
  • 技術的進步
  • 歷史概要
  • 合併及收購
  • 法規方案
  • 波特的五力分析
  • PEST分析

第4章 幹細胞治療的全球市場:各來源

  • 簡介
  • ES細胞
  • 成體幹細胞
  • 間質幹細胞
  • iPS細胞

第5章 幹細胞治療的全球市場:不同治療

  • 簡介
  • 同類幹細胞療法
  • 自體幹細胞療法

第6章 幹細胞治療的全球市場:各用途

  • 簡介
  • 腸胃疾病
  • 中樞神經系統疾病
  • 心血管疾病
  • 傷口
  • 眼疾
  • 免疫療法疾病
  • 肌肉骨骼障礙
  • 其他

第7章 幹細胞治療的全球市場:各終端用戶

  • 簡介
  • 醫院及診療所
  • 門診病人手術中心

第8章 幹細胞治療的全球市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 非洲
  • 中東

第9章 競爭情形

  • 熱圖分析
  • 企業簡介
    • Osiris Therapeutics, Inc.
    • Novartis AG
    • GlaxoSmithKline Plc.
    • MEDIPOST Co., Ltd
    • Anterogen Co., Ltd.
    • Pharmicell Co.Ltd.
    • Holostem Terapie Avanzate S.r.l
    • JCR Pharmaceuticals Co., Ltd.
    • NuVasive, Inc.
    • RTI Surgical, Inc.
    • Fibrocell Science, Inc.
  • 分析師的見解

第10章 章節

  • 參照資料
  • 調查方法
  • 關於Coherent Market Insight
目錄

Title:
Stem Cell Therapy Market, by Source (Embryonic Cells, Adult Stem Cells, Mesenchymal Stem Cells, and Induced Pluripotent Stem Cells) by Therapy Type (Allogeneic Stem Cell Therapy, and Autologous Stem cell Therapy),by Application (Gastro-Intestine Diseases, Central Nervous Diseases, Cardiovascular Diseases, Wounds and Injuries, Eye Diseases, Immune Therapy Diseases, Musculoskeletal Disorders, and Others), by End User (Hospitals and Clinics, and Ambulatory Surgical Centers), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Trends, and Forecast 2018 - 2026.

Stem cells are divided into two major classes; pluripotent and multipotent. Pluripotent cells are stem replicating cells which are derived from the embryo or fetal tissues. The pluripotent stem cells facilitate the development of cells and tissues in three primary germ layers such as mesoderm, ectoderm, and endoderm.

Market Dynamics:

Expansion of facilities related to stem cell therapies is expected to propel growth of the stem cell therapy market. For instance, in January 2018, the University of Florida, U.S. launched the Center for Regenerative Medicine that is focused on development of stem cell therapies for the treatment of damaged tissue and organ. The Centre for Regenerative Medicines is divided into two segments such as focus groups and shared services. Focus groups such as research and development activities for stem cell therapies; and the shared services segment provides technical resources related to stem cell therapies.

Furthermore, rising collaboration activities by key players are expected to drive growth of the global stem cell therapy market. For instance, in May 2018, Procella Therapeutics and Smartwise Medtech Company collaborated with AstraZeneca Pharmaceuticals. Under this collaboration, AstraZeneca was able to utilize Procella Therapeutics' stem cell technology for development of stem cell therapies in cardiovascular diseases.

Key features of the study:

  • This report provides in-depth analysis of the stem cell therapy market size (US$ Mn), and cumulative annual growth rate (CAGR (%)) for the forecast period: 2018 - 2026, considering 2017, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global stem cell therapy market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Osiris Therapeutics, Inc. Novartis AG, GlaxoSmithKline Plc., MEDIPOST Co., Ltd., Anterogen Co., Ltd. Pharmicell Co., Ltd. Holostem Terapie Avanzate S.r.l. JCR Pharmaceuticals Co., Ltd. NuVasive, Inc. RTI Surgical, Inc., and Fibrocell Science, Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global stem cell therapy market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for stem cell therapy market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Stem Cell Therapy Market, By Source:
    • Embryonic Stem Cells
    • Adult Stem Cells
    • Mesenchymal Stem Cells
    • Induced Pluripotent Stem Cells
  • Global Stem Cell Therapy market, By Therapy Type:
    • Allogeneic Stem Cell Therapy
    • Autologous Stem Cell Therapy
  • Global Stem Cell Therapy Market, By Application:
    • Gastro-Intestine Diseases
    • Central Nervous System Diseases
    • Cardiovascular Diseases
    • Wounds and Injuries
    • Eye Diseases
    • Immune Therapy Diseases
    • Musculoskeletal Disorders
    • Others
  • Global Stem Cell Therapy Market, By End User:
    • Hospitals and Clinics
    • Ambulatory Surgical Centers
  • Global Stem Cell Therapy Market, By Region:
    • North America
      • By Country:
    • U.S.
    • Canada
      • By Source:
    • Embryonic Stem Cells
    • Adult Stem Cells
    • Mesenchymal Stem Cells
    • Induced Pluripotent Stem Cells
      • By Therapy Type
    • Allogeneic Stem Cell Therapy
    • Autologous Stem Cell Therapy
      • By Application:
    • Gastro-Intestine Diseases
    • Central Nervous System Diseases
    • Cardiovascular Diseases
    • Wounds and Injuries
    • Eye Diseases
    • Immune Therapy Diseases
    • Musculoskeletal Disorders
    • Others
      • By End User:
    • Hospital and Clinics
    • Ambulatory Surgical Center
    • Europe
      • By Country:
    • U.K.
    • Germany
    • Italy
    • Spain
    • France
    • Russia
    • Rest of Europe
      • By Source:
    • Embryonic Stem Cells
    • Adult Stem Cells
    • Mesenchymal Stem Cells
    • Induced Pluripotent Stem Cells
      • By Therapy Type
    • Allogeneic Stem Cell Therapy
    • Autologous Stem Cell Therapy
      • By Application:
    • Gastro-Intestine Diseases
    • Central Nervous System Diseases
    • Cardiovascular Diseases
    • Wounds and Injuries
    • Eye Diseases
    • Immune Therapy Diseases
    • Musculoskeletal Disorders
    • Others
      • By End User:
    • Hospital and Clinics
    • Ambulatory Surgical Centers
    • Asia Pacific
      • By Country:
    • Australia
    • India
    • China
    • Japan
    • ASEAN
    • South Korea
    • Rest of Asia Pacific
      • By Source:
    • Embryonic Stem Cells
    • Adult Stem Cells
    • Mesenchymal Stem Cells
    • Induced Pluripotent Stem Cells
      • By Therapy Type
    • Allogeneic Stem Cell Therapy
    • Autologous Stem Cell Therapy
      • By Application:
    • Gastro-Intestine Diseases
    • Central Nervous System Diseases
    • Cardiovascular Diseases
    • Wounds and Injuries
    • Eye Diseases
    • Immune Therapy Diseases
    • Musculoskeletal Disorders
    • Others
      • By End User:
    • Hospital and Clinics
    • Ambulatory Surgical Centers
    • Latin America
      • By Country:
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
      • By Source:
    • Embryonic Stem Cells
    • Adult Stem Cells
    • Mesenchymal Stem Cells
    • Induced Pluripotent Stem Cells
      • By Therapy Type
    • Allogeneic Stem Cell Therapy
    • Autologous Stem Cell Therapy
      • By Application:
    • Gastro-Intestine Diseases
    • Central Nervous System Diseases
    • Cardiovascular Diseases
    • Wounds and Injuries
    • Eye Diseases
    • Immune Therapy Diseases
    • Musculoskeletal Disorders
      • By End User:
    • Hospital and Clinics
    • Ambulatory Surgical Centers
    • Middle East
      • By Country:
    • GCC
    • Israel
    • Rest of Middle East
      • By Source:
    • Embryonic Stem Cells
    • Adult Stem Cells
    • Mesenchymal Stem Cells
    • Induced Pluripotent Stem Cells
      • By Therapy Type
    • Allogeneic Stem Cell Therapy
    • Autologous Stem Cell Therapy
      • By Application:
    • Gastro-Intestine Diseases
    • Central Nervous System Diseases
    • Cardiovascular Diseases
    • Wounds and Injuries
    • Eye Diseases
    • Immune Therapy Diseases
    • Musculoskeletal Disorders
    • Others
      • By End User:
    • Hospital and Clinics
    • Ambulatory Surgical Centers
    • Africa
      • By Country:
    • South Africa
    • Central Africa
    • North Africa
      • By Source:
    • Embryonic Stem Cells
    • Adult Stem Cells
    • Mesenchymal Stem Cells
    • Induced Pluripotent Stem Cells
      • By Therapy Type
    • Allogeneic Stem Cell Therapy
    • Autologous Stem Cell Therapy
      • By Application:
    • Gastro-Intestine Diseases
    • Central Nervous System Diseases
    • Cardiovascular Diseases
    • Wounds and Injuries
    • Eye Diseases
    • Immune Therapy Diseases
    • Musculoskeletal Disorders
    • Others
      • By End User:
    • Hospital and Clinics
    • Ambulatory Surgical Centers
  • Company Profiles
    • Osiris Therapeutics, Inc. *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Novartis AG
    • GlaxoSmithKline Plc.
    • MEDIPOST Co., Ltd.
    • Anterogen Co., Ltd.
    • Pharmicell Co., Ltd.
    • Holostem Terapie Avanzate S.r.l.
    • JCR Pharmaceuticals Co., Ltd.
    • NuVasive, Inc.
    • RTI Surgical, Inc.
    • Fibrocell Science, Inc.

"*" marked represents similar segmentation in other categories in the respective section

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Source
    • Market Snippet, By Therapy Type
    • Market Snippet, By Application
    • Market Snippet By, End User
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Technology Advancements
  • Historical Overview
  • Merger and Acquisition
  • Regulatory Scenario
  • PORTER'S Five Forces
  • PEST Analysis

4. Global Stem Cell Therapy Market, By Source, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Embryonic Stem Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Adult Stem cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Mesenchymal Stem Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Induced Pluripotent Stem Cells
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

5. Global Stem Cell Therapy Market, By Therapy Type, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Allogeneic Stem Cell Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Autologous Stem cell Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

6. Global Stem Cell Therapy Market, By Application, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Gastro-Intestine Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Central Nervous System Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Cardiovascular Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Wounds and injuries
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Eye Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Immune Therapy Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Musculoskeletal Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

7. Global Stem Cell Therapy Market, By End User, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, 2017 - 2026
    • Segment Trends
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
  • Ambulatory Surgical centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)

8. Global Stem Cell Therapy Market, By Region, 2018 - 2026, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2018 and 2026 (%)
    • Y-o-Y Growth Analysis, By Region, 2017 - 2026
    • Regional Trends
  • North America
    • Market Size and Forecast, By Source, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Therapy Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Source, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Therapy Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Source, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Therapy Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Application 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Source , 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Therapy Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Million
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Source 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Therapy Type, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • North Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Source, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Therapy Type ,2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
    • Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East

9. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Osiris Therapeutics, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Novartis AG
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • GlaxoSmithKline Plc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • MEDIPOST Co., Ltd
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Anterogen Co., Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Pharmicell Co.Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Holostem Terapie Avanzate S.r.l
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • JCR Pharmaceuticals Co., Ltd.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • NuVasive, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • RTI Surgical, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
    • Fibrocell Science, Inc.
    • Company Overview
    • Product Portfolio
    • Financial Performance
    • Recent Highlights
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us and Sales Contact
Back to Top